Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy. Read more about Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy.
Infectious complications in patients with relapsed refractory multiple myeloma after BCMA CAR T-cell therapy. Read more about Infectious complications in patients with relapsed refractory multiple myeloma after BCMA CAR T-cell therapy.
Health-related quality of life with idecabtagene vicleucel in relapsed and refractory multiple myeloma. Read more about Health-related quality of life with idecabtagene vicleucel in relapsed and refractory multiple myeloma.
Successful treatment and integrated genomic analysis of an infant with FIP1L1-RARA fusion-associated myeloid neoplasm. Read more about Successful treatment and integrated genomic analysis of an infant with FIP1L1-RARA fusion-associated myeloid neoplasm.
Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation. Read more about Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation.
Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report. Read more about Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report.
Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia. Read more about Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia.
JMML tumor cells disrupt normal hematopoietic stem cells by imposing inflammatory stress through overproduction of IL-1β. Read more about JMML tumor cells disrupt normal hematopoietic stem cells by imposing inflammatory stress through overproduction of IL-1β.
Decreased IL-10 accelerates B-cell leukemia/lymphoma in a mouse model of pediatric lymphoid leukemia. Read more about Decreased IL-10 accelerates B-cell leukemia/lymphoma in a mouse model of pediatric lymphoid leukemia.
Consensus statement for the perinatal management of patients with α thalassemia major. Read more about Consensus statement for the perinatal management of patients with α thalassemia major.
